{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:08:22Z","timestamp":1791295702874,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.lpm.2010.10.017","type":"journal-article","created":{"date-parts":[[2011,1,6]],"date-time":"2011-01-06T09:28:04Z","timestamp":1294306084000},"page":"e87-e100","source":"Crossref","is-referenced-by-count":14,"special_numbering":"P2","title":["Pulmonary veno-occlusive disease: The b\u00eate noire of pulmonary hypertension in connective tissue diseases?"],"prefix":"10.1016","volume":"40","author":[{"given":"Dermot S.","family":"O\u2019Callaghan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dorfmuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Ja\u00efs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Sitbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald","family":"Simonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Montani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2010.10.017_bib0005","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1183\/09031936.00139009","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"34","author":"Gali\u00e8","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2010.10.017_bib0010","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2010.10.017_bib0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1183\/09059180.00003909","article-title":"Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension","volume":"18","author":"Palazzini","year":"2009","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.lpm.2010.10.017_bib0020","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.humpath.2006.11.022","article-title":"Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases","volume":"38","author":"Dorfmuller","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0025","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1148\/rg.273065194","article-title":"From the Archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis","volume":"27","author":"Frazier","year":"2007","journal-title":"Radiographics"},{"key":"10.1016\/j.lpm.2010.10.017_bib0030","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/01.CIR.80.5.1198","article-title":"Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry","volume":"80","author":"Pietra","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2010.10.017_bib0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-140-2-200401200-00013","article-title":"Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis","volume":"140","author":"Jimenez","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2010.10.017_bib0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00005792-200203000-00005","article-title":"Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival","volume":"81","author":"Scussel-Lonzetti","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2010.10.017_bib0045","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2010.10.017_bib0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.10.017_bib0055","first-page":"269","article-title":"Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma","volume":"33","author":"Chang","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0060","first-page":"1873","article-title":"Race, scleroderma, and survival: why is there a difference?","volume":"32","author":"Mayes","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0065","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1164\/rccm.200909-1331PP","article-title":"Systemic sclerosis-associated pulmonary arterial hypertension","volume":"181","author":"Le Pavec","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2010.10.017_bib0070","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.10.017_bib0075","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/art.24525","article-title":"The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France","volume":"60","author":"Hachulla","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.10.017_bib0080","first-page":"1055","article-title":"Pulmonary veno-occlusive disease and the CREST variant of scleroderma","volume":"8","author":"Morassut","year":"1992","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.lpm.2010.10.017_bib0495","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1183\/09031936.00081009","article-title":"A walk on the far side of the lung\u00a0\u2013\u00a0pulmonary venous involvement in patients suffering from systemic sclerosis-associated pulmonary arterial hypertension","volume":"35","author":"Dorfmuller","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2010.10.017_bib0090","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated Clinical Classification of Pulmonary Hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0095","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2010.10.017_bib0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF01230859","article-title":"Pulmonary veno-occlusion\u00a0\u2013\u00a0an immune complex disease?","volume":"364","author":"Corrin","year":"1974","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0105","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/01.pas.0000209834.69972.e5","article-title":"Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases","volume":"30","author":"Lantuejoul","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0110","first-page":"2161","article-title":"Pulmonary venoocclusive disease in a patient with systemic lupus erythematosus","volume":"20","author":"Kishida","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0115","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1191\/0961203306lu2283rr","article-title":"Mixed connective tissue disease","volume":"15","author":"Venables","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2010.10.017_bib0120","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/1529-0131(199905)42:5<899::AID-ANR8>3.0.CO;2-L","article-title":"Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings","volume":"42","author":"Burdt","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.10.017_bib0125","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00296-007-0362-1","article-title":"Pulmonary veno-occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease","volume":"27","author":"Zhang","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.lpm.2010.10.017_bib0130","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2010.10.017_bib0135","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MD.0b013e31818193bb","article-title":"Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology","volume":"87","author":"Montani","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2010.10.017_bib0140","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bmt.1705990","article-title":"Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction","volume":"41","author":"Bunte","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.lpm.2010.10.017_bib0145","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0169-5002(01)00479-2","article-title":"Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma","volume":"36","author":"Gagnadoux","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lpm.2010.10.017_bib0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.seminoncol.2005.11.006","article-title":"Vascular toxicity of antineoplastic agents","volume":"33","author":"Shahab","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2141.2003.04423.x","article-title":"Pulmonary veno-occlusive disease following allogeneic peripheral blood stem cell transplantation for chronic myeloid leukaemia","volume":"123","author":"Mukai","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0160","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1183\/09031936.93.06040596","article-title":"Pulmonary veno-occlusive disease and Hodgkin's lymphoma","volume":"6","author":"Swift","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2010.10.017_bib0165","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/jcp.2004.020735","article-title":"Segmental pulmonary veno-occlusive disease secondary to lung cancer","volume":"58","author":"Ibrahim","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0170","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00043426-200305000-00011","article-title":"Pulmonary veno-occlusive disease after autologous bone marrow transplant in a child with stage IV neuroblastoma: case report and literature review","volume":"25","author":"Trobaugh-Lotrario","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00007890-200001150-00030","article-title":"Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation","volume":"69","author":"Seguchi","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.lpm.2010.10.017_bib0180","first-page":"755","article-title":"Malignancy-associated pulmonary veno-occlusive disease: report of a case following autologous bone marrow transplantation and review","volume":"18","author":"Salzman","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.lpm.2010.10.017_bib0185","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0007-0971(85)90031-2","article-title":"Fatal pulmonary hypertension following renal transplantation","volume":"79","author":"Canny","year":"1985","journal-title":"Br J Dis Chest"},{"key":"10.1016\/j.lpm.2010.10.017_bib0190","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1183\/09031936.00044609","article-title":"Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis","volume":"34","author":"Jones","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2010.10.017_bib0195","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1034\/j.1399-3003.2000.15b33.x","article-title":"Pulmonary veno-occlusive disease in pulmonary Langerhans\u2019 cell granulomatosis","volume":"15","author":"Hamada","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2010.10.017_bib0200","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1365-2559.1986.tb02591.x","article-title":"Pulmonary veno-occlusive disease. A report of four cases","volume":"10","author":"Hasleton","year":"1986","journal-title":"Histopathology"},{"key":"10.1016\/j.lpm.2010.10.017_bib0205","first-page":"289","article-title":"Pulmonary veno-occlusive disease in a patient with a history of Hashimoto's thyroiditis","volume":"47","author":"Kokturk","year":"2005","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"10.1016\/j.lpm.2010.10.017_bib0210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/09031936.00090608","article-title":"Pulmonary veno-occlusive disease","volume":"33","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2010.10.017_bib0215","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1164\/rccm.200208-861OC","article-title":"Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II","volume":"167","author":"Runo","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2010.10.017_bib0220","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/humu.9398","article-title":"BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension","volume":"27","author":"Aldred","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.lpm.2010.10.017_bib0225","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/humu.20285","article-title":"Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension","volume":"27","author":"Machado","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.lpm.2010.10.017_bib0230","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.rmed.2010.03.014","article-title":"Pulmonary veno-occlusive disease: recent progress and current challenges","volume":"104S1","author":"Montani","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.lpm.2010.10.017_bib0235","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/rheumatology\/31.9.609","article-title":"HLA alleles in systemic sclerosis: association with pulmonary hypertension and outcome","volume":"31","author":"Langevitz","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0240","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2249.1999.00864.x","article-title":"Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein","volume":"116","author":"Okawa-Takatsuji","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0245","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2559.2008.03180.x","article-title":"Advances in the understanding and classification of pulmonary hypertension","volume":"54","author":"Stewart","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.lpm.2010.10.017_bib0250","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01230858","article-title":"The pathology of pulmonary veno-occlusive disease","volume":"364","author":"Wagenvoort","year":"1974","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0255","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1148\/rg.283075219","article-title":"From the archives of the AFIP: pulmonary alveolar proteinosis","volume":"28","author":"Frazier","year":"2008","journal-title":"Radiographics"},{"key":"10.1016\/j.lpm.2010.10.017_bib0260","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00428-008-0636-3","article-title":"Lymph node pathology in pulmonary veno-occlusive disease and pulmonary capillary heamangiomatosis","volume":"453","author":"de Montpreville","year":"2008","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.lpm.2010.10.017_bib0265","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.lpm.2009.09.013","article-title":"Maladie veino-occlusive et h\u00e9mangiomatose capillaire pulmonaire","volume":"39","author":"Montani","year":"2010","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2010.10.017_bib0270","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1161\/01.CIR.80.5.1486","article-title":"Primary pulmonary hypertension. The risk and benefit of lung biopsy","volume":"80","author":"Nicod","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2010.10.017_bib0275","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1183\/09059180.00005909","article-title":"Implementing the ESC\/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre","volume":"18","author":"Montani","year":"2009","journal-title":"Eur Resp Rev"},{"key":"10.1016\/j.lpm.2010.10.017_bib0500","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/eurheartj\/ehq170","article-title":"Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension","volume":"31","author":"Montani","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2010.10.017_bib0285","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2214\/ajr.183.1.1830065","article-title":"Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease","volume":"183","author":"Resten","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0290","first-page":"2347","article-title":"Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension","volume":"33","author":"Johnson","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0295","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1183\/09059180.00007209","article-title":"Diagnostic testing to guide the management of chronic thromboembolic pulmonary hypertension: state of the art","volume":"19","author":"Pepke-Zaba","year":"2010","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.lpm.2010.10.017_bib0300","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1164\/ajrccm.162.5.2003045","article-title":"High probability perfusion lung scans in pulmonary venoocclusive disease","volume":"162","author":"Bailey","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2010.10.017_bib0305","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1183\/09031936.06.00054105","article-title":"Occult alveolar haemorrhage in pulmonary veno-occlusive disease","volume":"27","author":"Rabiller","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2010.10.017_bib0310","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0889-857X(05)70336-7","article-title":"Alveolar hemorrhage in patients with rheumatic disease","volume":"23","author":"Dweik","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.lpm.2010.10.017_bib0315","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1378\/chest.118.6.1671","article-title":"Pulmonary veno-occlusive disease: a case series and new observations","volume":"118","author":"Holcomb","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2010.10.017_bib0320","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/art.23187","article-title":"High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis","volume":"58","author":"Allanore","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.10.017_bib0325","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1378\/chest.08-3042","article-title":"Is pulmonary arterial hypertension really a late complication of systemic sclerosis?","volume":"136","author":"Hachulla","year":"2009","journal-title":"Chest"},{"issue":"Suppl. 4","key":"10.1016\/j.lpm.2010.10.017_bib0330","doi-asserted-by":"crossref","first-page":"iv22","DOI":"10.1093\/rheumatology\/kel314","article-title":"Pulmonary arterial hypertension and rheumatic diseases--from diagnosis to treatment","volume":"45","author":"Distler","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2010.10.017_bib0335","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/rheumatology\/keh067","article-title":"Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis","volume":"43","author":"Mukerjee","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2010.10.017_bib0340","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccm.2006.12.003","article-title":"Standard therapies for pulmonary arterial hypertension","volume":"28","author":"Alam","year":"2007","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.lpm.2010.10.017_bib0345","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0755-4982(10)70004-X","article-title":"Traitement de l\u2019hypertension art\u00e9rielle pulmonaire","volume":"39","author":"Ja\u00efs","year":"2010","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2010.10.017_bib0350","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2010.10.017_bib0355","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2010.10.017_bib0360","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3899\/jrheum.081277","article-title":"Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol","volume":"36","author":"Badesch","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0365","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1378\/chest.108.6.1754","article-title":"Effect of prostacyclin on microvascular pressures in a patient with pulmonary veno-occlusive disease","volume":"108","author":"Davis","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2010.10.017_bib0370","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1378\/chest.113.1.237","article-title":"Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease","volume":"113","author":"Palmer","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2010.10.017_bib0375","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1183\/09031936.00017809","article-title":"Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease","volume":"34","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2010.10.017_bib0380","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1590\/S1806-37132008000900015","article-title":"Pulmonary veno-occlusive disease: diagnostic and therapeutic alternatives","volume":"34","author":"Barboza","year":"2008","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0385","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1590\/S0100-879X2005000200006","article-title":"One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease","volume":"38","author":"Barreto","year":"2005","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.lpm.2010.10.017_bib0390","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/thx.2007.088831","article-title":"Pulmonary veno-occlusive disease presenting with recurrent pulmonary oedema and the use of nitric oxide to predict response to sildenafil","volume":"63","author":"Creagh-Brown","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.lpm.2010.10.017_bib0395","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0954-6111(99)90079-3","article-title":"Effects of inhaled nitric oxide and aerosolized iloprost in pulmonary veno-occlusive disease","volume":"93","author":"Hoeper","year":"1999","journal-title":"Respir Med"},{"key":"10.1016\/j.lpm.2010.10.017_bib0400","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1183\/09031936.00054407","article-title":"Possible role of imatinib in clinical pulmonary veno-occlusive disease","volume":"32","author":"Overbeek","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2010.10.017_bib0405","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1378\/chest.123.2.344","article-title":"Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis","volume":"123","author":"Kawut","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2010.10.017_bib0410","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.22069","article-title":"Clinical differences between idiopathic and scleroderma-related pulmonary hypertension","volume":"54","author":"Fisher","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.10.017_bib0415","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ncprheum0048","article-title":"Drug insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases","volume":"1","author":"Humbert","year":"2005","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0420","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1183\/09031936.00106008","article-title":"Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy","volume":"34","author":"Overbeek","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2010.10.017_bib0425","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ccm.2006.11.011","article-title":"Combination therapy and new types of agents for pulmonary arterial hypertension","volume":"28","author":"O\u2019Callaghan","year":"2007","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.lpm.2010.10.017_bib0430","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1183\/09031936.05.00075305","article-title":"Goal-oriented treatment and combination therapy for pulmonary arterial hypertension","volume":"26","author":"Hoeper","year":"2005","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.lpm.2010.10.017_bib0505","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1183\/09031936.00102609","article-title":"Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution","volume":"34","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2010.10.017_bib0440","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jacc.2009.04.006","article-title":"Inflammation, growth factors, and pulmonary vascular remodeling","volume":"54","author":"Hassoun","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0445","first-page":"282","article-title":"Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment","volume":"29","author":"Tanaka","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0450","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/096120339300200606","article-title":"Pulmonary arterial hypertension responsive to immunosuppressive therapy in systemic lupus erythematosus","volume":"2","author":"Morelli","year":"1993","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2010.10.017_bib0455","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.23303","article-title":"Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases","volume":"58","author":"Jais","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.10.017_bib0460","first-page":"772","article-title":"Recovery from pulmonary hypertension with steroid therapy in a patient with Sj\u00f6gren's syndrome and polymyositis","volume":"21","author":"Mariette","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.10.017_bib0465","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1191\/0961203304lu509oa","article-title":"Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus","volume":"13","author":"Gonzalez-Lopez","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2010.10.017_bib0470","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/ard.2004.029074","article-title":"Effect of steroid pulse therapy on mixed connective tissue disease with pulmonary arterial hypertension","volume":"64","author":"Kamata","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2010.10.017_bib0475","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.130.1.182","article-title":"Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension","volume":"130","author":"Sanchez","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2010.10.017_bib0480","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.healun.2006.03.011","article-title":"International guidelines for the selection of lung transplant candidates: 2006 update\u00a0\u2013\u00a0a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation","volume":"25","author":"Orens","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.lpm.2010.10.017_bib0485","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1002\/art.22264","article-title":"Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension","volume":"54","author":"Schachna","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.10.017_bib0490","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1164\/ajrccm.162.5.9912045","article-title":"Pulmonary veno-occlusive disease","volume":"162","author":"Mandel","year":"2000","journal-title":"Am J Respir Crit Care Med"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498210006445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498210006445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T19:22:26Z","timestamp":1685906546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498210006445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0755498210006445"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2010.10.017","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}